Radiation-activated nanoparticles: Which combination to optimize radiosensitization?
Fiche publication
Date publication
août 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MIRJOLET Céline
Tous les auteurs :
Penninckx S, Martinive P, Mirjolet C
Lien Pubmed
Résumé
Radiotherapy plays a crucial role in the treatment of various cancers. With the ongoing technological advancements in radiotherapy equipment, allowing for increasingly precise targeting of tumours, there are numerous strategies being explored to enhance its effectiveness by combining it with other therapies. Among these, metal nanoparticles seem to have a promising future driven by their ability to locally amplify the dose deposited by ionizing radiation, and to radiosensitize cells by modifying their oxidative status. Recent advancements in understanding the mechanisms of action of these nanoparticles have provided valuable insights for the development of new therapeutic combinations. Among these, the combination with immunotherapies would make it possible to benefit both from the amplified local effect of radiotherapy by nanoparticles and to induce a better antitumour immune response. In this article, we review shortly the existing literature on ongoing combinations and suggest potential novel therapies associated with the combination of radiotherapy and nanoparticles.
Mots clés
Chemotherapy, Chimiothérapie, Combinaison, Combination, Immunotherapy, Immunothérapie, Nanoparticle, Nanoparticule, Personalization, Personnalisation, Radiotherapy, Radiothérapie
Référence
Cancer Radiother. 2023 08 4;: